The role of clinical and metabolic factors in the genesis and development of diabetic retinopathy;Uloga kliničkih i metaboličkih čimbenika u pojavi i razvoju dijabetičke retinopatije

Acta Medica Croatica

Volumn 62, Issue 1, 2008, Pages 23-27

  Galetović, Davor ^a   Karlica, Dobrila ^a   Bućan, Kajo ^a   Znaor, Ljubo ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

Apolipoprotein A; Apolipoprotein B; Diabetes mellitus; Diabetic retinopathy, hemoglobin A, glycosylated; Lipoproteins, HDL; Lipoproteins, LDL; Risk factors

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; LIPID;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL PROTOCOL; DIABETIC RETINOPATHY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; METABOLISM; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; ADULT; AGED; BLOOD; FEMALE; MALE; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 40649098594     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Zimmet P. Diabetes: definitions and classification. Medicine international 1993; 21: 237-9.
2. Metelko Ž, Lipovac M, Žmire J, Škrabalo Z, Prašek M, Granić M. Šećerna bolest. U: Vrhovac B i sur, ur. Interna medicina. Zagreb: Naprijed, 1991, 1308.
3. Eisenbarth GS. Type 1 diabetes. A chronic autoimmune disease. N Engl J Med 1986; 314: 1360-8.
4. Hitman GA. The immunogenetic of insulin-dependent diabetes. Eye 1993; 7: 209-13.
5. Šikić J. Mrežnica. U: Čupak K, ur. Oftalmologija. Zagreb: Nakladni zavod Globus, 1994, 611-28.
6. Vision problems in the U. S.: A Statistical Analysis. New York: National Sodety to Prevent Blindness, 1980.
7. Kahn HA, Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol 1974; 78: 58-67.
8. Brechner RJ, Cowie CC, Howie Lj i sur. Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA 1993; 270: 1714-18.
9. Hiller R, Krueger DE. Validity of a survey questions as measure of visual acuity impairment. Am J Public Health 1983; 73: 93-6.
10. Jennings Pe, Barnet AH. New approaches to the pathogenesis and treatment of diabetic microangiopathy. Diab Med 1998; 5: 111-7.
11. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
12. UKPDS Group: Intensive blood-glucose control with sulphonylurease or insulin compared with conventional treatment and risk of complication patient in type 2 diabetse (UKPDS33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1988; 352: 837-53.
13. Green DA, Lattimer SA, Sima AA. Sorbitol, phosphinosidase, and sodium-potassium-ATP-ase in the pathogenesis sf diabetic complications. N Engl J Med 1987; 316: 599-606.
14. Koya D. King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998; 47: 859-66.
15. Brownlee M. Negative consequence of glycation. Metabolism 2000; 49(Suppl 1): 9-13.
16. Gurler B, Vural H, Yilmaz N Oguz H, Satici A, Aksoy N. The role of oxidative stress in diabetic retinopathy. Eye 2005; 5: 730-35.
17. Ophthalmology Monographs. Diabetes and Ocular Disease. San Frandsco: American Academy of Ophthalmology, 2000, 14: 36-49.
18. Diabetes Mellitus. Report of a WHO Study Group (WHO Technical Report Series, No. 727). Geneva, Switzerland, 1985
19. Wu AHB, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the use of cardiac markers in coronary artery disease. Clin Chem 1999; 45: 1104-21.